Vision and Mission
CardioBird: Revolutionizing Animal Healthcare with Heart & Innovation.
We're on a mission to transform animal well-being, making quality veterinary care accessible and affordable for every animal, everywhere. We believe cutting-edge technology, powered by compassion, can change lives. That's why we're harnessing the power of AI and biosignal analysis to create innovative solutions for vets and pet owners alike.
Our purpose is simple: to build a better tomorrow for animals, our dedicated team, and the world we share. We're driven by core values: genuine care for every detail, unwavering consistency in our actions, and a champion mindset that pushes us to achieve excellence in all we do.
From developing groundbreaking diagnostic & monitoring tools to fostering a supportive community, we're committed to making a tangible difference in the lives of animals and the people who love them.
Join us. Let's build a better future, together – for animals and humans.
CardioBird Team
History
and
Achievements
2024
Selected for the Foreign Startup Commercialization Support Program/ GSC/ Korea.
Received the Fukuoka city award and was a finalist for the Asia Next Unicorn Award, Ramen Tech, Fukuoka, Japan.
Signed agreements with 5 out of 9 university veterinary schools in Korea and many others in Asia.
Established the world's largest veterinary ECG database with over 350,000 datasets.
2023
Released the CardioBird 2 device and platform.
Won 3rd place in the Korea Startup Grand Challenge (KSGC)/ Ministry of SMEs and Startups/ Korea
Won the Champion (representing Harvard University) at the ATEC (Asia Technology Entrepreneurship Conference)
2022
Received the "Small Pet Healthcare Product of the Year" award at the Independent Pet Innovation Award, USA.
2021
Won the Asia Smart App Award 2021.
2020
Established a distributor system in Taiwan, China and Korea (during the COVID-19 pandemic).
Received the Health Partnership Award 2020 - Outstanding Animal Heart Diagnostic Service.
2019
Closed the first closing of the USD 1.5M first equity investment round.
2018
Launched the CardioBird 1 device and platform.
Expanded to Taiwan.
Selected by AppWorks accelerator.
Signed contracts with 80 clinics; generating approximately 300 reports per month.
Became the Champion of the StartupGoGo pitch contest in Japan.
2017
Selected for the Hong Kong Science Park incubation support program.
Selected for the Federation of Hong Kong Industries STARS program.
2016
Selected by Zeroth AI, the first AI accelerator.
September 23, 2016.
Company founded